VISTAGEN THERAPEUTICS, INC. Increase (Decrease) in Other Operating Liabilities
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Increase (Decrease) in Other Operating Liabilities of -$230.70 thousand for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2021-02-11
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2020-12-31 was -$81.00K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2020-09-30 was -$77.50K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2020-06-30 was -$72.20K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other operating liabilities for the quarter ending 2019-12-31 was -$69.20K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month |
|---|---|---|---|
| 2020-12-31 | -$81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | -$158.50K derived: sum of 2 quarters · filed 2021-02-11 | -$230.70K 10-Q · filed 2021-02-11 |
| 2020-09-30 | -$77.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | -$149.70K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$72.20K 10-Q · filed 2020-08-13 | ||
| 2019-12-31 | -$69.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | -$135.20K derived: sum of 2 quarters · filed 2021-02-11 | -$196.30K 10-Q · filed 2021-02-11 |
| 2019-09-30 | -$66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | -$127.10K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$61.10K 10-Q · filed 2020-08-13 | ||
| 2018-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $0.00 10-Q · filed 2020-02-13 |
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |